1. Home
  2. BLLN vs FSLY Comparison

BLLN vs FSLY Comparison

Compare BLLN & FSLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLLN

BillionToOne Inc.

N/A

Current Price

$80.90

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Logo Fastly Inc.

FSLY

Fastly Inc.

HOLD

Current Price

$23.04

Market Cap

3.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
FSLY
Founded
2016
2011
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.5B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
BLLN
FSLY
Price
$80.90
$23.04
Analyst Decision
Buy
Hold
Analyst Count
7
7
Target Price
$126.71
$15.67
AVG Volume (30 Days)
281.7K
11.2M
Earning Date
03-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.19
EPS
N/A
N/A
Revenue
N/A
$624,018,000.00
Revenue This Year
$45.96
$16.43
Revenue Next Year
$30.11
$10.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.78
52 Week Low
$61.96
$5.13
52 Week High
$138.70
$34.82

Technical Indicators

Market Signals
Indicator
BLLN
FSLY
Relative Strength Index (RSI) 51.76 43.22
Support Level $80.39 $8.03
Resistance Level $83.20 N/A
Average True Range (ATR) 6.77 3.38
MACD 1.35 -0.73
Stochastic Oscillator 49.68 2.83

Price Performance

Historical Comparison
BLLN
FSLY

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About FSLY Fastly Inc.

Fastly Inc is a cloud computing company that provides an edge cloud platform designed to deliver, secure, and optimize digital experiences over the internet. The company operates a unified platform that combines content delivery, edge computing, and security capabilities. Its services include content delivery networks, web and API protection, distributed denial of service mitigation, and real-time data processing at the edge. Its platform enables customers to improve the performance, scalability, and security of applications and digital content, and also supports cloud-native architectures, AI-driven workloads, and programmable edge computing solutions.

Share on Social Networks: